Simvastatin-loaded graphene oxide embedded in polycaprolactone-polyurethane nanofibers for bone tissue engineering applications

Abstract

Here, the role of simvastatin-loaded graphene oxide embedded in polyurethane-polycaprolactone nanofibers for bone tissue engineering has been investigated. The scaffolds were physicochemically and mechanically characterized, and obtained polymeric composites were used as MG-63 cell culture scaffolds. The addition of graphene oxide-simvastatin to nanofibers generates a homogeneous and uniform microstructure as well as a reduction in fiber diameter. Results of water-scaffolds interaction indicated higher hydrophilicity and absorption capacity as a function of graphene oxide addition. Scaffolds’ mechanical properties and physical stability improved after the addition of graphene oxide. Inducing bioactivity after the addition of simvastatin-loaded graphene oxide terminated its capability for hard tissue engineering application, evidenced by microscopy images and phase characterization. Nanofibrous scaffolds could act as a sustained drug carrier. Using the optimal concentration of graphene oxide-simvastatin is necessary to avoid toxic effects on tissue. Results show that the scaffolds are biocompatible to the MG-63 cell and support alkaline phosphatase activity, illustrating their potential use in bone tissue engineering. Briefly, graphene-simvastatin-incorporated in polymeric nanofibers was developed to increase bioactive components’ synergistic effect to induce more bioactivity and improve physical and mechanical properties as well as in vitro interactions for better results in bone repair.

Nanotherapeutic approaches for delivery of long non-coding RNAs: an updated review with emphasis on cancer

“…Several biopolymers, including poly (-caprolactone), poly(D,L-glycolic acid), poly(D,L-lactic acid), and PEG, have been approved for use in macroformulations by the FDA. 195,196 These biopolymers can be used to create polymeric nanoparticles that transport and discharge therapeutic constituents more effectively than unbound drugs. By utilizing the EPR effect or by adding targeting molecules to their surface, it is also possible to target specific disease areas.…”

Recent Advances, Challenges and Future Opportunities for the Use of 3D Bioprinting in Large Bone Defect Treatment

“…Simvastatin can accelerate bone regeneration by regulating BMP-2 gene expression and show an osteoinductive role through the Ras signaling pathway, and activate mitogen-activated protein kinases. Also, it can inhibit bone density reduction using estrogen receptor-alpha or BMP-2 induction [66,67]. Feng et al [68] demonstrated the capability of simvastatin to enhance osteoblast differentiation of mesenchymal stem cells in osteoporosis Sprague-Dawley rats.…”

Pullulan as promoting endothelialization capacity of electrospun PCL-PU scaffold

“…They permit tissue formation with an inside layer of ECs surrounded by SMCs and their extracellular matrix. 18,19 Consequently, it seems the combination of Pl could yield some features analogous to the native tissue structure. This study aimed to create engineered vascular scaffolds based on PU-PCL-Pl and determine Pl effects on the scaffold's physicomechanical properties and endothelialization capacity in vitro.…”